February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 21, 2025

FDA Ends Semaglutide Shortage, Updates Policy

FDA declares resolution of nationwide semaglutide injection shortage and outlines 60 to 90 day transition periods for compounding facilities while other GLP-1 medications remain in limited supply.

Conexiant

February 21, 2025

Salt, Sour Taste Loss Raises Mortality Risk

Research shows that adults experiencing perceived taste loss face a higher risk of mortality, particularly when the ability to detect salt and sourness declines.

Conexiant

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 20, 2025

Long-Term Olive Oil Consumption Linked to Less Weight Gain

Findings from a 20+ year study of over 121,000 U.S. adults showed increased olive oil consumption was associated with less weight gain in middle age compared to other fats, such as butter, margarine, and other vegetable oils.

Conexiant

February 19, 2025

GALAD Score Enhances HCC Surveillance Accuracy

GALAD score improves hepatocellular carcinoma detection within 12 months of diagnosis, outperforming AFP in sensitivity and specificity, study shows.

Conexiant

February 19, 2025

Higher Calcium Intake Cuts Colorectal Cancer: Study

New NIH-AARP study of 471,396 participants shows increased calcium intake from all sources associated with significantly lower colorectal cancer risk over 20+ years of follow-up.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

CDC Reports Increase in Child and Severe Adult Obesity

From 2013 to 2023, severe obesity increased annually by 0.23 percentage points, according to new NHANES data.

Conexiant